Updates to the MRL-legislation

Recently, two new regulations 2019/38 and 2019/50 were published by the EU announcing adjustments to the MRLs. Regulation 2019/50 describes MRL adaptations of chlorantraniliprole, clomazone, cyclaniliprool, fenazaquin, fenpicoxamid, fluoxastrobin, lambda-cyhalothrin, mepiquat, onion oil, thiacloprid and valifenalate and will enter into force retroactively from 1 January 2019.

More information about MRL updates can be found on our website.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply